RETATRUTIDE - 10mg

Retatrutide supplied strictly for laboratory and scientific research purposes. This product is intended for in‑vitro and analytical research only. Not for human or veterinary use. Not a drug, supplement, or food product. All materials are provided as laboratory research chemicals and are not intended for consumption, injection, or medical use.

Retatrutide is a novel triple agonist peptide studied for human-relevant research on metabolic regulation, appetite control, and weight management. It combines GLP-1, GIP, and glucagon receptor activity to provide a comprehensive approach for investigating glycemic control, energy balance, and cardiometabolic health.

Key Features

🧪 cGMP manufactured in an FDA-registered facility

✅ ≥98% purity confirmed by HPLC analysis

📄 Batch-specific Certificates of Analysis (COAs) included

💉 Sterile, lyophilized vials for research use only

Human-Relevant Research Applications

⚡ Glycemic control and insulin sensitivity
• Improves glycemic markers (HbA1c, fasting glucose) in type 2 diabetes and metabolic syndrome contexts
https://pubmed.ncbi.nlm.nih.gov/40291085/

🏋️ Weight management and appetite regulation
• Leads to significant weight loss and reduces appetite/eating behaviours
https://pubmed.ncbi.nlm.nih.gov/40916752/

❤️ Cardiometabolic research
• Associated with better metabolic outcomes including weight, glucose, BMI, and blood pressure in clinical trials
https://pubmed.ncbi.nlm.nih.gov/39318607/

Mechanism Summary

Dual and triple receptor activity (GLP-1, GIP, glucagon) enhances glucose regulation and metabolic outcomes

Modulates satiety and energy homeostasis, supporting human-relevant research in obesity and diabetes

Enables studies on cardiometabolic health, weight loss, and insulin sensitivity

Frequently Research Questions

How does Retatrutide differ from GLP-1 analogues?
Retatrutide’s triple receptor activity offers broader metabolic and weight management effects than GLP-1 alone.

Is it suitable for long-term human-relevant studies?
Yes. It allows chronic investigation of insulin sensitivity, weight control, and cardiometabolic outcomes.

Does it affect cardiovascular markers?
Studies show beneficial effects on lipid profiles, blood pressure, and other cardiometabolic indicators.

Scientific References

📊 Frias et al. (2023) – Retatrutide triple agonist effects on glycemic control
• Retatrutide significantly lowers HbA1c and improves glucose control in adults with type 2 diabetes
https://pubmed.ncbi.nlm.nih.gov/37385280/

🏃 Jastreboff et al. (2023) – Triple agonist peptides and appetite/weight regulation
• Retatrutide produces substantial dose‑dependent weight loss and reduces appetite in adults with obesity
https://pubmed.ncbi.nlm.nih.gov/40916752/

Reconstitution & Handling Guidance

1- Use sterile bacteriostatic water (0.9% benzyl alcohol)

2- Add 3ml of Bacteriostatic Water for peptide econstitution

3- Gently swirl (do not vortex) until fully dissolved

4- Store reconstituted peptide at 4°C-10°C for 2-3 Months (Expiry)

5- Peptide not  reconstituted will last till the expiry date stored at 4°C-10°C

Legal & Research Disclaimer

This material is supplied exclusively for laboratory research use. It is not intended for diagnostic, therapeutic, cosmetic, human, or veterinary applications. The purchaser assumes all responsibility for compliance with applicable local, state, and federal regulations governing research compounds.

هذا المنتج مخصص للاستخدام البحثي والمخبري فقط، وغير مخصص للاستخدام البشري أو الحيواني.

⚠️ Important Notice This product is intended strictly for laboratory research use
 only.
Not for human use, medical, or veterinary purposes.
No clinical or dosage advice will be provided.